ALJAVTY Trademark

Trademark Overview

On Wednesday, February 23, 2022, a trademark application was filed for ALJAVTY with the United States Patent and Trademark Office. The USPTO has given the ALJAVTY trademark a serial number of 97280613. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, October 7, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The ALJAVTY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
aljavty

General Information

Serial Number97280613
Word MarkALJAVTY
Filing DateWednesday, February 23, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, October 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Saturday, February 26, 2022NEW APPLICATION ENTERED
Tuesday, March 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, August 1, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 1, 2023PETITION TO REVIVE-GRANTED
Tuesday, August 1, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 2, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, August 2, 2023PETITION TO REVIVE-GRANTED
Wednesday, August 2, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 2, 2023NOTICE OF REVIVAL - MAILED
Wednesday, August 2, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, August 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 27, 2023SOU EXTENSION 1 FILED
Friday, September 1, 2023SOU EXTENSION 1 GRANTED
Saturday, September 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 21, 2023SOU EXTENSION 2 FILED
Thursday, December 21, 2023SOU EXTENSION 2 GRANTED
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2024SOU EXTENSION 3 FILED
Tuesday, June 25, 2024SOU EXTENSION 3 GRANTED
Tuesday, June 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 7, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, February 10, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 10, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 10, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 10, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 10, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

aljavty disorders diseases preparations pharmaceutical treatment fertility hormone replacement dependence infectious